These 4 health care stocks are falling hard on earnings and dilution.
News & Analysis: Cleveland BioLabs
Clevland BioLabs' funding is uncertain, but not unattainable.
These underrated stocks could be tomorrow's big winners.
Analysts are unanimously bullish, but do you agree with these Wall Street darlings?
Investors are warming up to these previously unloved companies.
These stocks just rolled over. Can they come back?
Which stocks stand to gain from the stem cell trend?